Social Media Ideas for Jagx

Jaguar Health Reports Second Quarter 2026 Financials

Company remains sharply focused on its ongoing global development program for crofelemer for rare intestinal failure (IF) diseases; as announced, presentation at ESPGHAN 2026 descr...

Jaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercia...

As announced, Jaguar received an upfront payment of $16M of non-dilutive capital in January 2026 upon entering U.S. license agreement with Future Pak for Mytesi® and Canalevia®-CA1...

Jaguar Health to Hold Investor Webcast August 19 Regarding Q2 2026 Financials & Corporate Updates

Company plans to file its Earnings Report on August 19, 2026 on Form 10-Q for the quarter ended June 30, 2026

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failur...

Jaguar remains sharply focused on its ongoing global development program for oral crofelemer as adjunctive therapy to parenteral support (PS) for pediatric and adult rare IF diseas...

<![CDATA[Pharmaceutical Executive Daily: Jazz Acquires Actio Bioscience]]>

Jasper gets a lifeline in merger with immune drugmaker Kira

The acquisition, which involves a concurrent licensing deal with startup Mirador, gives Jasper a chance to rebound from setbacks that have wiped out most of its market value.  

Javelin Joint Venture and Tata Advanced Systems Signs Agreement for Missile Co-Production in India

Tata Advanced Systems Limited and the Javelin Joint Venture (JJV), a partnership between Raytheon, an RTX business, and Lockheed Martin (NYSE: LMT), have entered into a memorandum...

<![CDATA[Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion]]>

JAAA: Upgrading On Q2 Management Commentary

<![CDATA[Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement ]]>

Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consis...

Neonorm® Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool...

Jazz pays $820M to buy Actio, adding clinical-stage asset to orchestra of epilepsy therapies

Jazz Pharmaceuticals is adding to its orchestra of epilepsy treatments with the acquisition of Actio Biosciences for $820 million upfront.

Javelin Joint Venture And TATA Advanced Systems Signs Agreement For Missile Co-Production In India: Lockheed Martin

ORLANDO, Fla., August 30, 2026 – TATA Advanced Systems Limited and the Javelin Joint Venture (JJV), a partnership between Raytheon, an RTX business, and Lockheed Martin, have enter...

X4 Pharmaceuticals: Making Progress, But The Market Is Ahead Of The Trial (Rating Downgrade)

Jasper finds new purpose in merger with Kira, while offloading Tavneos rival to Mirador

Jasper Therapeutics is being reborn via a merger with Nasdaq-listed immune-mediated disease biotech Kira Pharmaceuticals.

Jazz to buy rare epilepsy drugmaker in potentially $1.3B deal

Actio Biosciences, which will receive $820 million up front in the deal, adds to a major upswing in private biotech buyouts seen throughout this year.

argenx SE (ARGX) Forte Biosciences, Inc. - M&A Call - Slideshow

Big Monthly Dividends: 3 Reasons JEPI Beats SPYI Right Now

argenx: Upgrading To Buy, The VYVGART Growth Cycle Has Further To Go

Janus Henderson Global Technology And Innovation Fund Q2 2026 Commentary

John Hancock Alternative Asset Allocation Fund Q2 2026 Commentary

Cullinan tees up J&J fight—and $100M payday—as Taiho-partnered drug hits phase 3 cancer goal

Taiho Pharmaceutical and Cullinan Therapeutics have celebrated a second phase 3 victory for their small-molecule EGFR inhibitor, teeing up the partners to challenge Johnson & J...

Argenx SE (ARGX) Prepares to Demonstrate Vyvgart’s Efficacy in Broader Autoimmune Diseases

Japex to buy US tight oil and gas assets for $320 million

(BOE Report) – Japan Petroleum Exploration said on Thursday it will acquire all equity interests in four Fundare companies holding […]